J. Ellegate

Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers

K. Eng, G. Chatta, M. Moffitt, 2022, Cancers.

MAGEC3 is a prognostic biomarker in ovarian and kidney cancers

K. Eng, G. Chatta, M. Moffitt, 2021, medRxiv.

Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers

K. Eng, J. Ohm, S. Rosario, 2022, medRxiv.